KLK3 and prostate cancer: The diagnostic roles of serum percentage α2,3-linked sialylated prostate-specific antigen (S2,3PSA%) and the Prostate Health Index (PHI) in predicting clinically significant prostate cancer (csPC) remain unclear in the context of magnetic resonance imaging (MRI)-guided biopsy.